Rheumatology NewsEuropean agency recommends two new adalimumab biosimilarsSeptember 20, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsLow RA flare rate reported after Pfizer COVID vaccinationSeptember 15, 2021Rheumatoid ArthritisCOVID-19 Updates
Rheumatology NewsThree JAK inhibitors get boxed warnings, modified indicationsSeptember 2, 2021Rheumatoid ArthritisPsoriatic ArthritisPediatrics
Pretreatment resistin levels tied to erosive disease risk in early RA treated with DMARD and infliximabAugust 29, 2021Rheumatoid Arthritis
Can iguratimod be regarded as a potential alternative to methotrexate in RA?August 29, 2021Rheumatoid Arthritis
No evidence of increased cancer incidence with long-term TNFi use in RAAugust 29, 2021Rheumatoid Arthritis
Risk for herpes zoster in RA higher with tsDMARDs/bDMARDs vs csDMARDsAugust 29, 2021Rheumatoid Arthritis
Higher anti-PC autoantibodies indicate lower risk for cardiovascular events in early RAAugust 29, 2021Rheumatoid Arthritis
Real-world comparative assessment of tofacitinib and baricitinib in RAAugust 29, 2021Rheumatoid Arthritis
Increased risk for vertebral fractures persists even with low-dose oral glucocorticoids for RAAugust 29, 2021Rheumatoid Arthritis
Rheumatology NewsNIH to study COVID vaccine booster in people with autoimmune diseaseAugust 27, 2021COVID-19 UpdatesRheumatoid ArthritisLupus & Connective Tissue Diseases
